Lachaud V, Coupry I, Podevin R A, Koenig E, Parini A
U 7 INSERM/UA 318 CNRS, département de pharmacologie, hôpital Necker, Paris.
Arch Mal Coeur Vaiss. 1989 Jul;82(7):1135-7.
Imidazolines have been proposed as highly selective drugs for alpha 2-adrenergic receptors. However, we have recently showed that the imidazoline ligand 3H-RX 781094 (idazoxan) binds to both alpha 2-receptors and imidazoline guanidinium receptive substance (IGRS) in rabbit renal proximal tubule. Binding of 3H-RX 781094 to the purified basolateral membranes (15-fold enriched in Na-KATPase activity) was rapid (t 1/2 = 5 mn.) reversible (t 1/2) = 4 mn.), saturable and of high affinity. Scatchard analysis of equilibrium binding data showed that 3H-RX 781094 labels 566 +/- 118 fmol/mg of proteins of binding sites with an apparent dissociation constant (Kd) of 1.45 +/- 0.14 nM. On the other hand, the non imidazoline ligand 3H-rauwolscine binds only to the alpha 2-adrenergic receptors with a maximal density of 155 +/- 28 fmol/mg of protein and a Kd of 11.5 +/- 1.5 nM. In order to define the relative affinity of the alpha-2-agonists, clonidine, rilmenidine and guanfacine for the two classes of receptors, we performed competition studies of the alpha 2-antagonists 3H-RX 781094 (imidazoline) and 3H-rauwolscine (non imidazoline) binding to basolateral membranes from rabbit proximal tubule. The order of potency for inhibition of the two radioligand binding was rilmenidine greater than clonidine greater than guanfacine for 3H-RX 781094 and clonidine greater than guanfacine greater than rilmenidine for 3H-rauwolscine. Therefore, rilmenidine displayed a higher affinity for IGRS than for alpha 2 adrenergic receptors; on the other hand, clonidine and guanfacine preferentially interact with alpha 2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)
咪唑啉类化合物被认为是α2 -肾上腺素能受体的高选择性药物。然而,我们最近发现咪唑啉配体3H - RX 781094(伊达唑胺)在兔肾近端小管中既能与α2 -受体结合,也能与咪唑啉胍基受体物质(IGRS)结合。3H - RX 781094与纯化的基底外侧膜(钠钾ATP酶活性富集15倍)的结合迅速(t1/2 = 5分钟)、可逆(t1/2 = 4分钟)、具有饱和性且亲和力高。对平衡结合数据进行Scatchard分析表明,3H - RX 781094标记的结合位点蛋白为566±118 fmol/mg,表观解离常数(Kd)为1.45±0.14 nM。另一方面,非咪唑啉配体3H - 育亨宾仅与α2 -肾上腺素能受体结合,最大密度为155±28 fmol/mg蛋白,Kd为11.5±1.5 nM。为了确定α2 -激动剂可乐定、利美尼定和胍法辛对这两类受体的相对亲和力,我们进行了α2 -拮抗剂3H - RX 781094(咪唑啉类)和3H - 育亨宾(非咪唑啉类)与兔近端小管基底外侧膜结合的竞争研究。对于3H - RX 78109来说,抑制两种放射性配体结合的效力顺序为利美尼定>可乐定>胍法辛;对于3H - 育亨宾来说,顺序为可乐定>胍法辛>利美尼定。因此,利美尼定对IGRS显示出比对α2 -肾上腺素能受体更高的亲和力;另一方面,可乐定和胍法辛优先与α2 -受体相互作用。(摘要截选至250字)